Utherapeptides, novel compounds, provide a potential strategy for advancing targeted drug delivery. These engineered peptides are capable of selectively binding to disease-specific cells, facilitating the delivery of therapeutic cargoes directly to the location of action. This accuracy reduces unintended effects and enhances clinical outcomes, possibly paving the way for https://jaredboxmi.acidblog.net/73966627/utherapeptides-the-future-of-targeted-drug-delivery